What Will Be Impact of Allowing Abortion Pill to be Mail-Ordered?

Earlier this month, as the debate over legal abortion in the U.S. intensified, the FDA removed a requirement that the pregnancy-ending drug mifepristone be dispensed only in clinics, medical offices and hospitals. That move will effectively open the door for “certified prescribers or pharmacies” in states that haven’t already banned the practice to dispense mifepristone by mail.

Experts tell AIS Health, however, that there are more questions than answers about how those loosened regulations will ultimately affect patient access to the controversial drug, as well as how industry players such as health plans and PBMs will be affected.

© 2022 MMIT

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured-Image-radar-on-specialty-pharmacy-MedPAC-Suggests-Biosimilars-Are-Helping-Bring-Down-ASPs.jpg
November 18

Medication Abortion Regulations, at a Glance

Read More
https://www.mmitnetwork.com/wp-content/uploads/2021/08/post-default-img.jpg
June 24

Experts Predict Home Delivery Of Rx Drugs Will Increase

Read More
https://www.mmitnetwork.com/wp-content/uploads/2021/08/post-default-img.jpg
April 8

Uber-ScriptDrop Deal Stirs Up Already Active Rx Delivery Space

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today